Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cipro, related antibiotics over-prescribed, fueling microbe resistance

30.09.2002


A new study heightens concerns that Cipro and related broad-spectrum antibiotics known as fluoroquinolones are being over-prescribed, accelerating bacterial resistance to the drugs and reducing their ability to treat infections.



The UCSF-led study evaluated the records of more than 13,000 patients across the country hospitalized for "community-acquired" pneumonia – pneumonia that developed before the patient was hospitalized. The researchers found that fluoroquinolones were widely prescribed to patients discharged from the hospital, even when tests showed that narrow-spectrum antibiotics were appropriate.

"Overuse of fluoroquinolones for infections that can be treated with narrow-spectrum antibiotics has seriously eroded their effectiveness," said Joseph Guglielmo, PharmD, UCSF professor of clinical pharmacy and director of the antimicrobial review program at the UCSF Medical Center.


Fluoroquinolones have been particularly useful in treating common bladder infections and infections associated with cystic fibrosis. "But we’ve seen dramatic increases in bacterial resistance to these agents over the past few years," Guglielmo said.

He presented the new findings in a poster session at the annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Diego.

The study found that 30 to 35 percent of patients with bacterial pneumonia due to penicillin-susceptible streptococcus were prescribed the broad-spectrum fluorquinolones upon discharge from the hospital. The American Thoracic Society recommends that the narrowest spectrum agent be chosen. Prescribing the broader-spectrum drug accelerates development of bacterial resistance to the antibiotics, Guglielmo said.

The E. coli bacterium is the most common cause of bladder infections, and Cipro and related fluoroquinolones are the most widely used and recommended antibiotic to treat these infections, Guglielmo said. As recently as 1997 the drugs were 97 percent active against E. coli. Now, susceptibility of this organism to fluororquinolones has dropped to 79 percent at UCSF, he said.

The situation is more alarming in relation to cystic fibrosis. Lung infections in people with cystic fibrosis traditionally have been treatable with fluoroquinolones. Cipro and related drugs are the only antibiotics patients can take orally to combat Pseudomonas aeurginosa, the most common bacterium associated with cystic fibrosis, Guglielmo said. Pills offer important quality- of- life benefits to patients who would otherwise need intravenous antibiotics.

However, in just 10 years Pseudomonas aeurginosa has become dramatically more resistant to these drugs. The drugs were 95 percent effective in 1992, and now that effectiveness has dropped to about 62 percent.

Wallace Ravven | EurekAlert!
Further information:
http://www.ucsf.edu/

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The spin state story: Observation of the quantum spin liquid state in novel material

New insight into the spin behavior in an exotic state of matter puts us closer to next-generation spintronic devices

Aside from the deep understanding of the natural world that quantum physics theory offers, scientists worldwide are working tirelessly to bring forth a...

Im Focus: Excitation of robust materials

Kiel physics team observed extremely fast electronic changes in real time in a special material class

In physics, they are currently the subject of intensive research; in electronics, they could enable completely new functions. So-called topological materials...

Im Focus: Electrons in the fast lane

Solar cells based on perovskite compounds could soon make electricity generation from sunlight even more efficient and cheaper. The laboratory efficiency of these perovskite solar cells already exceeds that of the well-known silicon solar cells. An international team led by Stefan Weber from the Max Planck Institute for Polymer Research (MPI-P) in Mainz has found microscopic structures in perovskite crystals that can guide the charge transport in the solar cell. Clever alignment of these "electron highways" could make perovskite solar cells even more powerful.

Solar cells convert sunlight into electricity. During this process, the electrons of the material inside the cell absorb the energy of the light....

Im Focus: The lightest electromagnetic shielding material in the world

Empa researchers have succeeded in applying aerogels to microelectronics: Aerogels based on cellulose nanofibers can effectively shield electromagnetic radiation over a wide frequency range – and they are unrivalled in terms of weight.

Electric motors and electronic devices generate electromagnetic fields that sometimes have to be shielded in order not to affect neighboring electronic...

Im Focus: Gentle wall contact – the right scenario for a fusion power plant

Quasi-continuous power exhaust developed as a wall-friendly method on ASDEX Upgrade

A promising operating mode for the plasma of a future power plant has been developed at the ASDEX Upgrade fusion device at Max Planck Institute for Plasma...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Contact Tracing Apps against COVID-19: German National Academy Leopoldina hosts international virtual panel discussion

07.07.2020 | Event News

International conference QuApps shows status quo of quantum technology

02.07.2020 | Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

 
Latest News

X-ray scattering shines light on protein folding

10.07.2020 | Life Sciences

Looking at linkers helps to join the dots

10.07.2020 | Materials Sciences

Surprisingly many peculiar long introns found in brain genes

10.07.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>